SCHEMBL2884265

SCHEMBL2884265

CSc1nc(-c2ccc(-c3ccc(F)cc3)cc2)cc2c(Br)cnn12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
L3MBTL1 Q9Y468 4/20 0.39
CSNK2A1 P68400 1/20 0.38
KDM4E B2RXH2 5/20 0.36
HPGD P15428 4/20 0.36
HSD17B10 Q99714 3/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CHEK1 O14757 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CCNA1 P78396 1/20 0.36
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
GAA P10253 2/20 0.35
MGAM O43451 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
MAPK1 P28482 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2882426 0.86 CDK2 (0.36) CHEK1CCNA2CDK2CCNA1
SCHEMBL2882168 0.85 RAB9A (0.43) ALDH1A1CSNK2A1KDM4EHPGDHSD17B10
SCHEMBL2881754 0.80 MAPT (0.39) ALDH1A1KDM4EHPGDHSD17B10NPC1
SCHEMBL2877011 0.78 ALDH1A1 (0.41) ALDH1A1L3MBTL1CSNK2A1KDM4EHPGD
SCHEMBL2880067 0.76 SMN1; SMN2 (0.44) ALDH1A1CSNK2A1KDM4EHPGDNPC1
SCHEMBL2213285 0.75 MAPK14 (0.39) ALDH1A1L3MBTL1CSNK2A1KDM4EHPGD
SCHEMBL2213284 0.65 NPC1 (0.38) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL5592977 0.64 ALDH1A1 (0.64) ALDH1A1L3MBTL1KDM4ERAB9ASMN1; SMN2
SCHEMBL2877008 0.64 KDM4E (0.43) ALDH1A1CSNK2A1KDM4EHPGDNPC1
SCHEMBL31351818 0.62 KDM4E (0.52) ALDH1A1L3MBTL1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745446-B2 Pyrazolo[1,5-c]pyrimidines BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-29 US disclosed
US-20070254046-A1 Novel Pyrazolopyrimidines ALTANA PHARMA AG (DE) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254046-A1 Novel Pyrazolopyrimidines MCL1, RARS2, CDK4 ALDH1A1 1334/4885L3MBTL1 529/4885CSNK2A1 1044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.